Y-mAbs Therapeutics, Inc.

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Report date

6/30/2025

Quarter

2025 Q2

Filed

8/14/2025

Shares

51,090

Value ($000)

230

Weight

0.0%

2020 Q1 - 2025 Q2 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q2	8/14/2025	230	0.0%	51,090	6/30/2025
2025 Q1	5/14/2025	269	0.0%	60,660	3/31/2025
2024 Q4	2/14/2025	223	0.0%	28,489	12/31/2024
2024 Q1	5/7/2024	364	0.0%	22,415	3/31/2024
2023 Q4	2/14/2024	113	0.0%	16,640	12/31/2023
2023 Q3	11/14/2023	124	0.0%	22,710	9/30/2023
2023 Q2	8/11/2023	333	0.0%	49,019	6/30/2023
2023 Q1	5/16/2023	245	0.0%	48,833	3/31/2023
2022 Q4	2/14/2023	169	0.0%	34,634	12/31/2022
2022 Q3	11/14/2022	558	0.0%	38,668	9/30/2022
2022 Q2	8/15/2022	327	0.0%	21,626	6/30/2022
2022 Q1	5/16/2022	409	0.0%	34,417	3/31/2022
2021 Q4	2/14/2022	491	0.0%	30,280	12/31/2021
2021 Q3	11/15/2021	759	0.0%	26,579	9/30/2021
2021 Q2	8/11/2021	539	0.0%	15,947	6/30/2021
2021 Q1	5/17/2021	584	0.0%	19,326	3/31/2021
2020 Q4	2/16/2021	337	0.0%	6,815	12/31/2020
2020 Q3	11/16/2020	204	0.0%	5,314	9/30/2020
2020 Q2	8/14/2020	232	0.0%	5,377	6/30/2020
2020 Q1	5/15/2020	330	0.0%	12,630	3/31/2020